Ito N, Kang H, Michigami T, Namba N, Kubota T, Shintani A
Calcif Tissue Int. 2025; 116(1):50.
PMID: 40074938
PMC: 11903609.
DOI: 10.1007/s00223-025-01359-9.
Ouyang W, Xiao B, Chen H, Fu L, Tang F, Marrone G
Front Nutr. 2025; 12:1547181.
PMID: 39963666
PMC: 11831048.
DOI: 10.3389/fnut.2025.1547181.
Tamura K, Sakai M, Iwamoto T, Yoshida S, Oshikawa J
JMA J. 2025; 8(1):57-59.
PMID: 39926059
PMC: 11799659.
DOI: 10.31662/jmaj.2024-0221.
Okubo R, Ohigashi T, Kondo M, Tsunoda R, Kai H, Saito C
BMC Nephrol. 2024; 25(1):414.
PMID: 39563222
PMC: 11575120.
DOI: 10.1186/s12882-024-03849-8.
Deng S, Binte Sayeed U, Wagatsuma Y
Cureus. 2024; 16(10):e71276.
PMID: 39525109
PMC: 11550912.
DOI: 10.7759/cureus.71276.
'DKD' as the kidney disease relevant to individuals with diabetes.
Kanasaki K, Nangaku M, Ueki K
Diabetol Int. 2024; 15(4):673-676.
PMID: 39469547
PMC: 11512933.
DOI: 10.1007/s13340-024-00747-0.
Factors Associated With Sacubitril/Valsartan Continuation and the Methods of Combining Heart Failure Medications in Patients With Heart Failure.
Iwasaki E, Kohyama N, Inamoto M, Nagao M, Sunaga T, Suzuki H
Ann Pharmacother. 2024; 59(4):301-310.
PMID: 39229914
PMC: 11874506.
DOI: 10.1177/10600280241277354.
Relationship between the combination of platelet count and neutrophil-lymphocyte ratio and prognosis of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study.
Kashimura S, Sato M, Inagaki T, Kin M, Manabe R, Kusumoto S
Thorac Cancer. 2024; 15(28):2049-2060.
PMID: 39193939
PMC: 11444929.
DOI: 10.1111/1759-7714.15437.
Effect of Frequent Computed Tomography Examinations with Contrast Media on the Renal Function of Patients with Oral Squamous Cell Cancer and an Evaluation of Risk Factors for Post-Operative Chronic Kidney Disease.
Hasegawa T, Matsuda A, Amano R, Saito I, Takeda D, Kakei Y
J Maxillofac Oral Surg. 2024; 23(4):824-830.
PMID: 39118931
PMC: 11303357.
DOI: 10.1007/s12663-023-02015-1.
Diabetic kidney disease: the kidney disease relevant to individuals with diabetes.
Kanasaki K, Ueki K, Nangaku M
Clin Exp Nephrol. 2024; 28(12):1213-1220.
PMID: 39031296
PMC: 11621156.
DOI: 10.1007/s10157-024-02537-z.
High sodium intake and fluid overhydration predict cardiac structural and functional impairments in chronic kidney disease.
Duan S, Ma Y, Lu F, Zhang C, Guo H, Zeng M
Front Nutr. 2024; 11:1388591.
PMID: 38860161
PMC: 11164051.
DOI: 10.3389/fnut.2024.1388591.
Association between preoperative phase angle and all-cause mortality after cardiovascular surgery: A retrospective cohort study.
Shibata K, Kameshima M, Adachi T, Kito H, Tanaka C, Sano T
J Cachexia Sarcopenia Muscle. 2024; 15(4):1558-1567.
PMID: 38859616
PMC: 11294016.
DOI: 10.1002/jcsm.13514.
Evaluating the associations between compliance with CKD guideline component metrics and renal outcomes.
Nyma Z, Kitaoka K, Yano Y, Kanegae H, Bayaraa N, Kishi S
Sci Rep. 2024; 14(1):11481.
PMID: 38769367
PMC: 11106300.
DOI: 10.1038/s41598-024-62152-6.
PIONEER REAL Japan: Baseline characteristics of a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in clinical practice in Japan.
Suzuki R, Amadid H, Major-Pedersen A, Yabe D
J Diabetes Investig. 2024; 15(8):1047-1056.
PMID: 38711208
PMC: 11292382.
DOI: 10.1111/jdi.14219.
Impact of Age on Prescribing Patterns of Cardiovascular Medications in Older Japanese Patients with Non-Dialysis-Dependent Chronic Kidney Disease: A Cross-Sectional Study.
Tanaka S, Kitamura H, Tsuruya K, Kitazono T, Nakano T
J Atheroscler Thromb. 2024; 31(10):1427-1442.
PMID: 38631869
PMC: 11456346.
DOI: 10.5551/jat.64798.
Dotinurad restores exacerbated kidney dysfunction in hyperuricemic patients with chronic kidney disease.
Amano H, Kobayashi S, Terawaki H
BMC Nephrol. 2024; 25(1):97.
PMID: 38491453
PMC: 10943825.
DOI: 10.1186/s12882-024-03535-9.
Mathematical expansion and clinical application of chronic kidney disease stage as vector field.
Kanda E, Epureanu B, Adachi T, Sasaki T, Kashihara N
PLoS One. 2024; 19(3):e0297389.
PMID: 38478478
PMC: 10936765.
DOI: 10.1371/journal.pone.0297389.
New-onset Kidney Biopsy-proven Membranous Nephropathy Induced End-stage Kidney Disease in a Living Donor.
Morioka F, Nakatani S, Mori K, Naganuma T, Yamasaki T, Uedono H
Intern Med. 2024; 63(18):2537-2541.
PMID: 38346741
PMC: 11473275.
DOI: 10.2169/internalmedicine.2814-23.
Long-Term Impact of Renin-Angiotensin System Inhibitors for Secondary Prevention in Patients with Chronic Kidney Disease Who Underwent Percutaneous Coronary Intervention.
Fukase T, Dohi T, Nishio R, Takeuchi M, Takahashi N, Chikata Y
Kidney Dis (Basel). 2024; 10(1):39-50.
PMID: 38322627
PMC: 10843199.
DOI: 10.1159/000532055.
Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care.
Svensson M, Murohara T, Lesen E, Arnold M, Cars T, Jarbrink K
Nephrol Dial Transplant. 2024; 39(8):1258-1267.
PMID: 38253386
PMC: 11334062.
DOI: 10.1093/ndt/gfae016.
